… Of those who were infected, 7% had a high viral load, 9% moderate viral load, and 84%
low viral load based on Ct values. The probability of transmission in those with high …

… monotherapy and combination therapy with bamlanivimab and etesevimab on severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in mild to moderate COVID-19. …

… moderate COVID-19 outpatients resulted in several findings. First, we found a correlation
between initial viral load… of patients with mild-to-moderate COVID-19 in which serial respiratory …

… or mild patients with COVID-19 … viral load and prevalence of pneumonia in young COVID-19
patients with asymptomatic or mild disease severity. In this retrospective study, 106 COVID-…

… COVID‐19 and classified according to severity as asymptomatic (16.2%), mild (59.6%),
moderate (… Our study has indicated that children with COVID‐19 have similar amount of viral load …

… time to critical COVID-19 … moderate COVID-19 at a high-risk of progression to severe or
critical disease. Another reason to treat early COVID-19 is to reduce viral load because viral load …

… viral load was independently associated with mortality among patients hospitalized with
COVID-19. … So the difference in viral loads between moderately affected and critically ill patients …

… antibodies ETE or sotrovimab results in a significant reduction in viral load in early treatment
of patients with mild-to-moderate COVID-19. Safety data showed that the frequencies of …

… Key secondary outcomes were the change from baseline to day 7 in the SARS-CoV-2 viral
load and a persistently high SARS-CoV-2 viral load on day 7 (defined as a log viral load >5.27…

… Specifically, I 2 = 0 indicated no heterogeneity, while we considered low, moderate and
high degrees of heterogeneity based on the values of I 2 of <25%, 25–75% and above 75%, …